Alteration in pancreatic immunoreactivity of insulin-like growth factor (IGF)-binding protein (IGFBP)-6 and in intracellular degradation of IGFBP-3 in fibroblasts of IGF-II receptor/IGF-II-deficient mice

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 235-241

  Braulke, Thomas ^a   Dittmer, F ^a   Gotz W ^a   Von Figura, K ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

IGF2R IGF II deficiency; IGFBP endocytosis; IGFBPs; Mouse mutants; Pancreas IGFBP proteolysis

Indexed keywords

CATHEPSIN D; HYDROLASE; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FIBROBLAST; HORMONE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PANCREAS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALIA;

EID: 0032921259     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978724     Document Type: Article

References (42)

1. 1. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345: 78-80
2. 2. Werner J, Leroith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996; 68: 183-223
3. 3. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev 1995; 16: 143-63
4. 4. Hartmann H, Meyer-Alber A, Braulke T. Metabolic actions of insulin-like growth factor II in cultured adult rat hepatocytes are not mediated through the insulin-like growth factor II receptor. Diabetologia 1992; 35: 216-23
5. 5. Morrione A, Valentinis B, Xu S-Q, Yumet G, Louvi A, Efstratiadis A, Baserga R. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci USA 1997; 94: 3777-82
6. 6. Kornfeld S. Structure and function of the mannose 6-phosphate/ insulin-like growth factor II receptors. Ann Rev Biochem 1992; 61: 307-30
7. 7. Braulke T. Origin of lysosomal proteins. In: Lloyd JB, Mason RW (eds). Subcellular Biochemistry: Biology of the lysosome. New York, Plenum Press 1996; 27: 15-49
8. 8. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 1996; 177: 517-35
9. 9. Louvi A, Accili D, Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 1997; 189: 33-48
10. 10. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 1995; 16: 3-34
11. 11. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H. Matrix metalloproteinases degrade insulin-like growth factor binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994; 269: 25742-6
12. 12. Cohen P, Graves HCB, Peehl DM, Kamarei M, Guidice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992; 75: 1046-53
13. 13. Kübler B, Cowell S, Zapf J, Braulke T. Proteolysis of insulin-like growth factor binding protein by a novel 50-kilodalton metalloproteinase in human pregnancy serum. Endocrinology 1998; 139: 1556-63
14. 14. Conover CA, De Leon DD. Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. J Biol Chem 1994; 269: 7076-80
15. 15. Claussen M, Kübler B, Wendland M, Neifer K, Schmidt B, Zapf J, Braulke T. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 1997; 138: 3797-803
16. 16. Lau MMH, Stewart GEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994; 8: 2953-63
17. 17. Sohar I, Sleat D, Liu C-G, Ludwig T, Lobel P. Mouse mutants lacking the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor are impaired in lysosomal enzyme transport: comparison of cation-independent and cation-dependent mannose 6-phosphate receptor-deficient mice. Biochem J 1998; 330: 903-8
18. 18. Claussen M, Buergisser D, Schuller AGP, Matzner U, Braulke T. Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-11-overexpressing NIH 3T3 cells. Mol Endocrinol 1995; 9: 902-12
19. 19. Putzer P, Breuer P, Gross M, Götz W, Kübler B, Scharf J-G, Schuller AGP, Hartmann H, Braulke T. Mouse insulin-like growth factor binding protein-6: expression, purification, characterization and histochemical localization. Mol Cell Endocrinol 1998; 137: 69-78
20. 20. Wang ZQ, Fung MR, Barlow DP, Wagner EF. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/ Mpr gene. Nature 1994; 372: 464-7
21. 21. Braulke T, Götz W, Claussen M. Immunohistochemical localization of insulin-like growth factor binding protein-1,-3 and -4 in human fetal tissues and their analysis in media from fetal tissue explants. Growth Regulation 1996; 6: 55-65
22. 22. Herner F, Körner C, Braulke T. Phosphorylation of the human 46 kDa mannose 6-phosphate receptor in the cytoplasmic domain at serine 56. J Biol Chem 1993; 268: 17108-13
23. 23. von Figura K. Secretion of β-hexosaminidase by cultured human skin fibroblasts. Exp Cell Res 1978; 111: 15-21
24. 24. Moses AC, Nissley SP, Short PA, Rechler MM, White RM, Knight AB, Higo OZ. Increased levels of multiplication stimulating activity, an insulin-like growth factor, in fetal rat serum. Proc Natl Acad Sci USA 1980; 77: 3649-53
25. 25. Martin JL, Baxter RC. Insulin-like growth factor binding proteins (IGFBPs) produced by human skin fibroblasts immunological relationship to other human IGFBPs. Endocrinology 1989; 123: 1053-60
26. 26. Hill DJ, Camacho-Hubner C, Rashid P, Strain AJ, Clemmons DR. Insulin-like growth factor binding protein secretion by human fibroblasts: dependence on cell density and IGF peptides. J Endocrinol 1989; 122: 87-98
27. 27. Scharf J-G, Ramadori G, Braulke T, Hartmann H. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulin-like growth factor, and growth hormone. Hepatology 1996; 23: 818-27
28. 28. Martin JL, Willetts KE, Baxter RC. Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 1990; 265: 4124-30
29. 29. Martin JL, Coverley JA, Baxter RC. Regulation of immunoreactive insulin-like growth factor binding protein-6 in normal and transformed human fibroblasts. J Biol Chem 1997; 269: 11470-7
30. 30. Bach LA, Leeding KS, Leng SL. Regulation of IGF-binding protein-6 by dexamethasone and IGFs in PC12 rat phaeochromocytoma cells. J Endocrinol 1997; 155: 225-32
31. 31. Hogg J, Han VKM, Clemmons DR, Hill DJ. Interactions of nutrients, insulin-like growth factors (IGFs) and IGF-binding proteins in the regulation of DNA synthesis by isolated fetal rat islets of Langerhans. J Endocrinol 1993; 138: 401-12
32. 32. Yoshida T, Hanahan D. Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncoj;ene into the islets of Langerhans. Amer J Pathol 1994; 145: 671-84
33. 33. Höög A, Hu W, Abdel-Halim SM, Falkmer S, Qing L, Grimelius L Ultrastructural localization of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: a study in normal and diabetic (GK) rats. Ultrastruc Pathol 1997; 21: 457-66
34. 34. Reinecke M, Betzler D, Drakenberg K, Falkmer S, Sara VR. Occurrence of members of the insulin superfamily in central nervous system and digestive tract of protochordates. Histochemistry 1993; 99: 277-85
35. 35. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 1991 ; 88: 580-4
36. 36. Rajkumar K, Dheen ST, Murphy LJ. Hyperglycemia and impaired glucose tolerance in insulin-like growth factor binding protein-1 transgenic mice. Amer J Physiol 1996; 270: E565-E571
37. 37. Dheen ST, Rajkumar K, Murphy LJ. Islet cell proliferation and apoptosis in insulin-like growth factor binding protein-1 transgenic mice. J Endocrinol 1997; 155: 551-8
38. 38. Braulke T, Claussen M, Saftig P, Wendland M, Neifer K, Schmidt B, Zapf J, von Figura K, Peters C. Proteolysis of ICFBPs by cathepsin D in vitro and in cathepsin D-deficient mice. Prog Growth Factor Res 1995; 6: 265-71
39. 39. Pohlmann R, Wendland M, Boeker C, von Figura K. The two mannose 6-phosphate receptors transport distinct complements of lysosomal proteins. J Biol Chem 1995; 270: 27311-8
40. 40. Oh Y, Müller HL, Pham H, Rosenfeld R. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 1993; 268: 26045-8
41. 41. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 1997; 272: 12181-8
42. 42. Leal SM, Liu Q, Huang SS, Huang JS. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 1997; 272: 20572-6